![Michael Ortiz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Ortiz formerly worked at Sequoia Capital, as Senior Director from 2020 to 2024 and Roivant Sciences Ltd., as Head of Public Affairs from 2017 to 2020.
Mr. Ortiz received his undergraduate degree from Stanford University.
| Companies | Position | End |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 31/07/2020 |
Sequoia Capital
 Sequoia Capital Investment ManagersFinance Sequoia Capital seeks investment opportunities in companies across the globe. The firm targets companies operating across a broad range of sectors. It provides financing for pre-seed, seed, early and growth capital requirements. | Private Equity Investor | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sequoia Capital
Sequoia Capital Investment ManagersFinance Sequoia Capital seeks investment opportunities in companies across the globe. The firm targets companies operating across a broad range of sectors. It provides financing for pre-seed, seed, early and growth capital requirements. | Finance |
Select your edition
All financial news and data tailored to specific country editions
